David A. Barbie
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
interferon and immune responses, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1(2009)4,112 cited
- → Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma(2018)1,980 cited
- → A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade(2018)1,406 cited
- → Mechanisms of resistance to immune checkpoint inhibitors(2018)1,328 cited
- → CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2017)756 cited
- → Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors(2018)689 cited
- → NPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcription(2000)669 cited
- → STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment(2016)618 cited
- → Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine(2014)565 cited
- → Highly parallel identification of essential genes in cancer cells(2008)563 cited